Skip Ribbon Commands
Skip to main content
Menu
Back To Search Results
Assoc Prof Kenneth Chen

Assoc Prof Kenneth Chen

MBBS, MCI, DFD (CAW), MRCS (Edin), FAMS (Urology), FRCS Uro (Glasgow)

Senior Consultant

Singapore General Hospital

Specialty: Urology

Clinical Interest: General Urology, Uro-Oncology, Minimally Invasive Surgery

Conditions Treated by this Doctor:
Adrenal Gland Cancer, Benign Prostatic Hyperplasia (BPH), Bladder Cancer, Kidney Cancer, Penile Cancer, Prostate Cancer, Robotic and Laparoscopic Surgery, Testicular Cancer, Urological Cancers.

Clinical Appointments

  • Senior Consultant Urology Singapore General HospitalSingapore General Hospital
  • High-risk Bladder Cancer Clinic Singapore General HospitalSingapore General Hospital

Academic Appointments

  • Clinical Associate Professor, Duke-NUS Graduate Medical School
  • Clinical Senior Lecturer with the National University of Singapore Yong Loo Lin School of Medicine
  • Clinical Teacher Faculty Lee Kong Chian School of Medicine, Singapore
  • SingHealth Physician Faculty for PGY1 Program - Urology
  • Core Faculty Member for Singhealth Urology Residency Program

Profile

Dr. Kenneth Chen is a senior consultant uro-oncologist at Singapore General Hospital. He earned his medical degree (MBBS) from the National University of Singapore in 2007 and completed a 6-year residency in Urology with Singhealth and has cleared his specialist board exams with distinction, having obtained the Academy of Medicine, College of Surgeons GOLD medal for best performing advanced surgical trainee in Urology. Besides obtaining membership and fellowship to the Royal College of Surgeons (Edinburgh and Glasgow), he also holds a Masters in Clinical Investigation. 

Dr. Chen specialises in robotic and minimally invasive surgery for genitourinary oncology, having completed an oncology fellowship at the Sir Peter MacCallum Cancer Centre in Melbourne, Australia. His academic and research interests include prostate cancer diagnostics, advanced prostate cancer management, and novel device development. He has been awarded a National Medical Research Council (NMRC) grant for work on a drug-eluting stent to treat ureteric diseases. 

In addition to his clinical work and research, Dr. Chen serves as a clinical associate professor at Duke-NUS Graduate Medical School and a senior clinical lecturer at the National University of Singapore YLL School of Medicine and the Lee Kong Chian School of Medicine. He is also involved in the nurturing and training of residents being a Singhealth Physician Faculty for Postgraduate year 1 Program as well as a core faculty member for the Singhealth Urology Residency Program. 

He contributes widely in the hospital, serving as deputy director of the Singapore General Hospital Robotic Surgery Committee, member of the hospital’s Pharmacy and Therapeutics Committee, Research Grant Review Committee, Clinical Translational Research Committee and Clinical Trials & Research Centre (CTRC) Executive Committee and past member of the Singapore General Hospital Medical Board. He is the current treasurer of the Singapore Urological Association. Dr. Chen is also a member of several international committees, including the Société Internationale d'Urologie (SIU) Innovators Committee and the International Bladder Cancer Group (iBCG).

Education

  • Fellow of the Academy of Medicine Singapore
  • Masters of Clinical Investigation (NUS)
  • Fellow of Royal College of Surgeons (Glasgow) (Urology)
  • Member of Royal College of Surgeons (Edinburgh) 
  • Bachelor of Medicine, Bachelor of Surgery (NUS)

Professional Appointments and Committee Memberships

  • Deputy Chair of SGH Robotic Surgery Committee (2024-present)
  • Member of Singapore General Hospital Pharmacy and Therapeutics Committee (2019-present)
  • Member of SGH Research Grant (SRG) Review Committee (1 April 2022 – 31 March 2024)
  • Member of SGH Clinical Translational Research Committee (2023-present)
  • Member of SGH Clinical Trials & Research Centre (CTRC) Executive Committee (1 Jan 2023 – 31 Dec 2024)
  • Member of Singapore Urological Association (Full)
  • Member of Singapore Urological Association Executive Committee (2022-present)
  • Treasurer Singapore Urological Association Executive Committee (2024-present)
  • Member of Société Internationale d'Urologie (SIU) Innovators Committee (2022-present)
  • Member of International Bladder Cancer Group (IBGC) (2024-present)

Awards

  • 2024 - Service with a Heart (Singhealth)
  • 2023 - Antibiotic Champion (awarded by Antimicrobial Stewardship Unit, SGH)
  • 2023 - Outstanding Faculty Award (Singhealth RiSE Awards)
  • 2023 - Service with a Heart (Singhealth)
  • 2020 - Singapore Health Quality Service Award (Gold)
  • 2018 - College of Surgeons Singapore GOLD Medal in Urology (Best performing advanced surgical trainee in Urology)
  • 2018 - Nurturing Clinician Scientist Scheme (Singhealth Surgery ACP)
  • 2017 - NMRC MOH Healthcare Research Scholarship (MCI program)
  • 2017 - Singapore Health Quality Service Award (Silver)
  • 2017 - Outstanding Resident Award (Singhealth)
  • 2016 - Outstanding Resident Award (Singhealth)
  • 2015 - Outstanding Resident Award (Singhealth)
  • 2007 - Best Houseman Award (TTSH General Surgery)

Research Interests

  • Novel Device Development
  • Drug eluting ureteric stents
  • Prostate Cancer Diagnostics
  • Biomarkers in prostate cancer,
  • Multidisciplinary Care in Metastatic Prostate Cancer

Publications

  1. Chen K, Thng J, Ho D, Lawrentschuk N. Clinical Practice Guide: Management of Chylous Ascites After Retroperitoneal Lymph Node Dissection. Eur Urol Focus. 2024 May 13:S2405-4569(24)00067-1. doi: 10.1016/j.euf.2024.05.005. Epub ahead of print. PMID: 38744565.
  2. Chin J, Tan YG, Lee A, Ng TK, Shi R, Tang CYL, Thang SP, Tuan JKL, Cheng CWS, Tay KJ, Ho HSS, Wang HJ, Chiu PK, Teoh JY, Lam WW, Law YM, Yuen JSP, Chen K. "Seeing Is Believing": Additive Utility of 68Ga-PSMA-11 PET/CT in Prostate Cancer Diagnosis. Cancers (Basel). 2024 May 5;16(9):1777. doi: 10.3390/cancers16091777. PMID: 38730729; PMCID: PMC11083035.
  3. Chiong E, Murphy DG, Buchan N, Chen K, Chen SS, Chua MLK, Hamid AR, Kanesvaran R, Khochikar M, Letran J, Lojanapiwat B, Mallik I, Ng CF, Ong TA, Poon DMC, Pu YS, Saad M, Schubach K, Takahara K, Tey J, Thang SP, Toh PC, Türkeri L, Vinh NT, Williams S, Ye D; ANZUP Cancer Trials Group; Davis ID. Management of advanced prostate cancer in the Asia-Pacific region: Summary of the Asia-Pacific Advanced Prostate Cancer Consensus Conference 2023. Asia Pac J Clin Oncol. 2024 Apr 16. doi: 10.1111/ajco.14064. Epub ahead of print. PMID: 38628049.
  4. Khi Yung Fong, Valerie Huei Li Gan, Benjamin Jia Han Lim, Yiong Huak Chan, Daniele Castellani, Kenneth Chen, Kae Jack Tay, Henry Sun Sien Ho, John Shyi Peng Yuen, Edwin Aslim, Jeremy Teoh, Ee Jean Lim. Off-clamp vs on-clamp robot-assisted partial nephrectomy: a systematic review and meta-analysis. BJU Int. (JIF 5.969)
  5. Ee Jean Lim, Mengyue Su, B M Saiduzzaman, Kae Jack Tay, Henry Sun Sien Ho, Theodoros Tokas, Bhaskar Kumar Somani, Vineet Gauhar, John Shyi Peng Yuen, Kenneth Chen. Oligometastatic Prostate Cancer-The Middle Child Syndrome. J Clin Med 2023 Nov 21;12(23):7198. doi: 10.3390/jcm12237198. (JIF 4.964)
  6. Jeffrey J Leow, Ee Jean Lim, Kenneth Chen. Re: Electronic medical records – a disappointing mirage for clinicians and research. (JIF 5.969)
  7. Renu S Eapen, James P Buteau, Price Jackson, Catherine Mitchell, Sheng F Oon, Omar Alghazo, Lachlan McIntosh, Nattakorn Dhiantravan, Mark J Scalzo, Jonathan O'Brien, Shahneen Sandhu, Arun A Azad, Scott G Williams, Gaurav Sharma, Mohammad B Haskali, Mathias Bressel, Kenneth Chen, PocharapongJenjitranant, Aoife McVey, Daniel Moon, Nathan Lawrentschuk, Paul J Neeson, Declan G Murphy, Michael S Hofman. Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study. Eur Urol 2023 Oct 25:S0302-2838(23)03087-7. doi: 10.1016/j.eururo.2023.08.026. Online ahead of print. (IF 24.344)
  8. Clyve Yu Leon Yaow, Han Jie Lee, Seth En Teoh, Ryan Ian Houe Chong, Tze Kiat Ng, Kae Jack Tay, Henry Ho, Yan Mee Law, Jeffrey Tuan, John Yuen, Kenneth Chen. Local Therapy on Clinically Lymph Node-positive Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol Oncol. 2023 Sep 18:S2588-9311(23)00175-X. doi: 10.1016/j.euo.2023.09.002. PMID: 37730526. (JIF 8.208)
  9. Chen K, Ong S, Vasundhara K, Mun CK, Williams I, Kanesvaran R, Peng JYS, Azad AA, Lawrentschuk N. Is genetic testing coming of age in advanced prostate cancer? BJU Int. 2023 Jul 27. doi: 10.1111/bju.16139. Epub ahead of print. PMID: 37498948. (JIF 5.969)
  10. Yang X, Tan YG, Gatsinga R, Chen W, Huang HH, Loong JTK, Chua MLK, Rajasekaran T, Kanesvaran R, Tay KJ, Chen K, Yuen JSP. Far from the truth: Real-world treatment patterns among newly diagnosed metastatic prostate cancer in the era of treatment intensification. Int J Urol. 2023 Jul 11. doi:10.1111/iju.15243. (JIF 2.896)
  11. Lee AYM, Chen K, Cheng CWS, Ho HSS, Yuen JSP, Ngo NT, Law YM, Tay KJ. Intensive sampling of the umbra and penumbra improves clinically significant prostate cancer detection and reduces risk of grade group upgrading at radical prostatectomy. World J Urol. 2023 Jul 3. doi: 10.1007/s00345-023-04499-5. (JIF 3.661)
  12. Kelly BD, Ptasznik G, Roberts MJ, Doan P, Stricker P, Thompson J, Buteau J, Chen K, Alghazo O, O'Brien JS, Hofman MS, Frydenberg M, Lawrentschuk N, Lundon D, Murphy DG, Emmett L, Moon D. A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy. Eur Urol Open Sci. 2023 Jun 2;53:90-97. doi: 10.1016/j.euros.2023.05.002. (JIF 2.5)
  13. Marc Diocera, Kenneth Chen, Declan G. Murphy, Nathan Lawrentschuk, Daniel Moon, Renu Eapen, Jeremy Goad, Emma Birch. Migration of an established pre-operative education session for robot-assisted radical prostatectomy patients to telehealth: A quality improvement initiative. Int J Urol Nurs. 2023; 17(2): 145-146. (JIF 0.72)
  14. Chow Kit Mun, So Wei Zheng, Lee Han Jie, Alvin Lee, Dominic Wei Ting Yap, Yemisi Takwoingic, Tay Kae Jack, Jeffrey Tuan, Thang Sue Ping, Winnie Lam, John Yuen, Nathan Lawrentschuk, Michael S.Hofman, Declan G.Murphy, Kenneth Chen. Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. 2023 Jul;84(1):36-48. doi: 10.1016/j.eururo.2023.03.001. Epub 2023 Apr 7. (IF 24.344)
  15. Chow KM, Chen K, Yuen J.S.P. Robotic-assisted Laparoscopic non-dismembered side-to-side tapered neoureterocystostomy – a technique for maximal ureteric vascular preservation in megaureter patients. Urology Video Journal Volume 17, March 2023, 100208. (JIF 2.633)
  16. Chen, K., Tay, K.J., Yuen, J.S.P., Lawrentschuk, N. (2022). Training with New Robots and How to Transition from One System to the Next in Renal Cancer Surgery. In: Goonewardene, S.S., Persad, R., Albala, D. (eds) Robotic Surgery for Renal Cancer. Management of Urology. Springer, Cham. 
  17. Chen, K. and Lawrentschuk, N. (2023), Case of the Month from Peter MacCallum Cancer Centre, Melbourne, Australia: ICG-assisted robotic Boari flap ureteric reimplantation in a case of missed ureteric injury. BJU Int, 131: 46-49. (IF 5.969)
  18. Chen K, O'Brien J, McVey A, Jenjitranant P, Kelly BD, Kasivisvanathan V, Lawrentschuk N, Murphy DG, Azad AA. Combination treatment in metastatic prostate cancer: is the bar too high or have we fallen short? Nat Rev Urol 2023 Feb;20(2):116-123. doi: 10.1038/s41585-022-00669-z. (IF 16.43)
  19. McDonald J, O'Brien J, Kostos L, Lawrentschuk N, Azad AA, Murphy D, Chen K. Systemic therapy in metastatic hormone-sensitive prostate cancer. Curr Opin Support Palliat Care. 2022 Oct 14. doi: 10.1097/SPC.0000000000000622. Epub ahead of print. PMID: 36239736. (IF 2.302)
  20. Williams IS, McVey A, Perera S, O'Brien JS, Kostos L, Chen K, Siva S, Azad AA, Murphy DG, Kasivisvanathan V, Lawrentschuk N, Frydenberg M. Modern paradigms for prostate cancer detection and management. Med J Aust. 2022 Oct 17;217(8):424-433. doi: 10.5694/mja2.51722. Epub 2022 Oct 2. PMID: 36183329. (IF 12.776)
  21. Chow KM, Tay KJ, Yuen J, Chen K. The role of surgery for loco-regional and advanced urological cancers. Curr Opin Urol. 2022 Nov 1;32(6):634-642. doi:10.1097/MOU.0000000000001036. Epub 2022 Sep 13. PMID: 36101519. (IF 2.808)
  22. Leow JJ, Chen K, Yuen JSP. Editorial Comment from Dr Leow et al. to Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guerin failure in non-muscle invasive bladder cancer. Int J Urol. 2022 Oct;29(10):1205-1206. doi: 10.1111/iju.15037. Epub 2022 Sep 12. PMID: 36094833. (IF 2.896)
  23. Ong S, Chen K, Grummet J, Yaxley J, Scheltema MJ, Stricker P, Tay KJ, Lawrentschuk N. Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus? BJU Int. 2022 Sep 9. doi: 10.1111/bju.15883. Epub ahead of print. PMID: 36083229. (IF 5.969)
  24. Chen K, Kostos L, Azad AA. Future directions in systemic treatment of metastatic hormone-sensitive prostate cancer. World J Urol 2023 Aug;41(8):2021-2031. doi: 10.1007/s00345-022-04135-8.. PMID: 36029329. (IF 3.661)
  25. O'Brien JS, Teh J, Kelly BD, Chen K, Manning T, Furrer M, Chee J, Lawrentschuk N. Interrogating the Impassable: A Case Series and Literature Review of Unilateral SPECT-CT Groin Visualization in Men With Penile Cancer. Front Surg. 2022 May 18;9:882011. doi: 10.3389/fsurg.2022.882011. PMID: 35662824; PMCID: PMC9157642. (IF 2.568)
  26. Chen K, McVey A, Kasivisvanathan V, Jenjitranant P, Azad A, Murphy DG. Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer. Eur Urol. 2022 Jul;82(1):146-147. doi: 10.1016/j.eururo.2022.03.018. Epub 2022 Mar 25. PMID: 35346516. (IF 24.344)
  27. Chen K, Ong S, Lawrentschuk N. Biomarkers Accurately Inform Treatment Decisions in Localised Prostate Cancer. Eur Urol Focus. 2022 Mar 22:S2405-4569(22)00065-7. doi: 10.1016/j.euf.2022.03.011. Epub ahead of print. PMID: 35337775. (IF 5.996)
  28. Chen K, O'Brien J, McVey A, Kasivisvanathan V, Murphy DG. Re: Armando Stabile, Antony Pellegrino, Elio Mazzone, et al. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard. Eur Urol Oncol 2022;5:1-17. Eur Urol Oncol. 2022 Mar 21:S2588-9311(22)00034-7. doi: 10.1016/j.euo.2022.03.003. Epub ahead of print. PMID: 35331682. (IF 8.512)
  29. O'Brien JS, Teh J, Chen K, Kelly BD, Chee J, Lawrentschuk N. Dynamic Sentinel Lymph Node Biopsy for Penile Cancer: Accuracy is in the Technique. Urology. 2022 Jun;164:e308. doi: 10.1016/j.urology.2022.02.014. Epub 2022 Mar 11. PMID: 35283135. (IF 2.633)
  30. Lim EJ, Fong KY, Li J, Huang HH, Chen K, Tay KJ, Cheng CWS, Ho HSS, Ngo NT, Yuen JSP. Clinicopathological features of non-conventional renal cell carcinoma histological subtypes: Learning points from a large contemporary series spanning over three decades. Investig Clin Urol. 2022 Mar;63(2):151-158. doi: 10.4111/icu.20210373. PMID: 35244988; PMCID: PMC8902431. (IF 1.902)
  31. O'Brien J, Chen K, Murphy DG. Accuracy Versus Impact: The Referee Verdict on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Staging of Prostate Cancer. Eur Urol Open Sci. 2021 Nov 17;34:83-85. doi: 10.1016/j.euros.2021.09.010. PMID: 34825226; PMCID: PMC8604740. (IF 3.000)
  32. Lee AYM, Chen K, Tan YG, Lee HJ, Shutchaidat V, Fook-Chong S, Cheng CWS, Ho HSS, Yuen JSP, Ngo NT, Law YM, Tay KJ. Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy-implications on clinically-significant prostate cancer detection and relevance to focal therapy planning. Prostate Cancer Prostatic Dis 2022 Apr;25(4):720-726. doi: 10.1038/s41391-021-00485-3. Epub 2022 Jan 14. (IF 5.455)
  33. Tan YG, Fang AHS, Lim JKS, Khalid F, Chen K, Ho HSS, Yuen JSP, Huang HH, Tay KJ. Incorporating artificial intelligence in urology: Supervised machine learning algorithms demonstrate comparative advantage over nomograms in predicting biochemical recurrence after prostatectomy. Prostate. 2022 Feb;82(3):298-305. doi: 10.1002/pros.24272. Epub 2021 Dec 2. PMID: 34855228. (IF 4.104)
  34. Lee A, Chen K, Tay KJ. Can We Avoid a Systematic Biopsy in Men with PI-RADS® 5? Letter. J Urol. 2022 Jan;207(1):240-241. doi: 10.1097/JU.0000000000002298. Epub 2021 Oct 19. PMID: 34664526. (IF 7.641)
  35. Chen K, Murphy D, Lawrentschuk N. Active Surveillance for Low-Risk Prostate Cancer: The Uphill Battles and the Unnecessary Ones. J Urol. 2022 Feb;207(2):265-267. doi: 10.1097/JU.0000000000002348. Epub 2021 Nov 17. PMID: 34788547. (IF 7.641)
  36. Lee AY, Yang XY, Lee HJ, Law YM, Huang HH, Sim AS, Lau WK, Lee LS, Cheng CW, Ho HS, Yuen JS, Tay KJ, Chen K. Limitations of overlapping cores in systematic and MRI-US fusion biopsy. Urol Oncol. 2021 Nov;39(11):782.e15-782.e21. doi: 10.1016/j.urolonc.2021.02.027. Epub 2021 Apr 20. PMID: 33888423. (IF 2.954)
  37. Lee AY, Chen K, Law YM, Ho HS, Cheng CW, Yuen JS, Tay KJ. Robot-assisted Magnetic Resonance Imaging-ultrasound Fusion Transperineal Targeted Biopsy. Urology. 2021 Sep;155:46. doi: 10.1016/j.urology.2021.06.008. Epub 2021 Jun 26. PMID: 34186128. (IF 2.649)
  38. Tan YG, Quek SZH, Huang HH, Ho HSS, Yuen JSP, Tay KJ, Tuan JKL, Chen K. Serum testosterone levels and testosterone 'bounce' phenomenon predict response to novel anti-androgen therapies in castration-resistant prostate cancer. Urol Oncol. 2021 May 19:S1078-1439(21)00166-6. doi: 10.1016/j.urolonc.2021.04.009. Epub ahead of print. PMID: 34023195. (IF 2.954)
  39. Low AW, Chen K, Tan YG, Ng TK, Yuen JSP. Ambulatory robot-assisted laparoscopic radical prostatectomy with extended recovery by total extraperitoneal approach. Int J Urol. 2021 May;28(5):561-565. doi: 10.1111/iju.14509. Epub 2021 Feb 7. PMID: 33550690. (IF 2.896)
  40. Lee HJ, Lee A, Yang XY, Law YM, Huang HH, Lau WK, Lee LS, Ho HS, Cheng CW, Yuen JS, Tay KJ, Chen K. External validation and comparison of magnetic resonance imaging-based predictive models for clinically significant prostate cancer. Urol Oncol. 2021 Mar 25:S1078-1439(21)00113-7. doi: 10.1016/j.urolonc.2021.03.003. Epub ahead of print. PMID: 33775528. (IF 2.954)
  41. Tan YG, Khalid F, Huang HH, Chen K, Tay KJ, Lau WKO, Cheng CWS, Ngo NT, Yuen JSP. Prostatic ductal adenocarcinoma variant predicts worse pathological and oncological outcomes: Insight from over 1000 consecutive patients from a large prospective uro-oncology registry. Prostate 2021 Mar;81(4):242-251. doi: 10.1002/pros.24100. Epub 2021 Jan 11. (IF 4.104)
  42. Gatsinga R, Chen W, Chen K, Tay KJ, Yuen JSP, Tan YG. Affordable and underutilized: the paradox of surgical castration. Transl Androl Urol. 2022 Dec;11(12):1618-1620. doi: 10.21037/tau-22-696. PMID: 36632165; PMCID: PMC9827401. (JIF 2.479)
  43. Tan YG, Poon RJ, Pang LJ, Villanueva A, Huang HH, Chen K, Ng TK, Tay KJ, Ho HS, Yuen JS. Comparative study of surgical orchidectomy and medical castration in treatment efficacy, adverse effects and cost based on a large prospective metastatic prostate cancer registry. Urol Oncol. 2020 Aug;38(8):682.e1-682.e9. doi: 10.1016/j.urolonc.2020.05.005. Epub 2020 May 29. PMID: 32475745 (IF 2.954)
  44. Lee A, Lee HJ, Huang HH, Tay KJ, Lee LS, Sim SPA, Ho SSH, Yuen SPJ, Chen K. Prognostic Significance of Inflammation-associated Blood Cell Markers in Nonmetastatic Clear Cell Renal Cell Carcinoma. Clin Genitourin Cancer. 2020Aug;18(4):304-313. doi: 10.1016/j.clgc.2019.11.013. Epub 2019 Dec 4. PMID: 31892491. (IF 2.896)
  45. Yu Guang Tan, Shu Hui Neo, Kenneth Chen, Guan Chou Teh, Christian Schwentner, Allen Soon Phang Sim. Key surgical techniques in laparoscopic nephrectomy and thrombectomy for advanced renal cell carcinoma with thrombosis. Urology Video Journal, Volume 2 2019, 100008, ISSN 2590-0897, https://imsva91-ctp.trendmicro.com:443/wis/clicktime/v1/query?url=https%3a%2f%2fdoi.org%2f10.1016%2fj.urolvj.2019.100008&umid=20E1219C-1C81-7006-83F0-35164058FEEE&auth=6e3fe59570831a389716849e93b5d483c90c3fe4-87006d975c9c06ce042edeb28a27c68f1ac87488. (JIF 2.633)
  46. Jingzeng Du, Tze K. Ng, Kenneth Chen, Allen S.P. Sim, Keong T. Foo, and John S.P. Yuen. Transurethral Enucleation and Resection of Prostate Made Easy. Videourology 2019 33:3 (JIF 2.619)
  47. Lee AY, Yang XY, Lee HJ, Law YM, Hong HH, Lau WK, Lee LS, Ho HS, Tay KJ, Cheng CW, Yuen JS, Chen K. Multiparametric MRI-Ultrasound Software Fusion Prostate Biopsy - Initial Results Using a Stereotactic Robotic Assisted Transperineal Prostate Biopsy Platform Comparing Systematic Versus Targeted Biopsy. BJU Int 2020 Nov;126(5):568-576. doi: 10.1111/bju.15118..PMID: 32438463 (IF 5.969)
  48. Yu Guang Tan, Mohamad Farhan Bin Khalid, Andre Villanueva, Hong Hong Huang, Kenneth Chen and Allen Soon Phang Sim. Are small renal masses all the same? Int J Urol. 2020 May;27(5):439-447. doi: 10.1111/iju.14219. Epub 2020 Mar 23. PMID: 32207186 (IF 2.896)
  49. Yu Guang Tan, Kenneth Chen, Allen Soon Phang Sim. Robotic anatrophic nephrolithotomy: An alternative in managing complex renal stone. Urology Video Journal, Volume 5, 2020, 100026, ISSN 2590-0897, (JIF 2.633)
  50. Tan YG, Pang L, Khalid F, Poon R, Huang HH, Chen K, Tay KJ, Lau W, Cheng C, Ho H, Yuen J. Local and systemic morbidities of de novo metastatic prostate cancer in Singapore: insight from 685 consecutive patients from a large prospective Uro-oncology registry. BMJ Open. 2020 Feb 18;10(2):e034331. doi: 10.1136/bmjopen-2019-034331. (IF 3.007)
  51. Yang X, Lee AY, Law YM, Sim ASP, Tay KJ, Lau WKO, Ho HSS, Yuen JSP, Chen K. Stereotactic robot-assisted transperineal prostate biopsy under local anaesthesia and sedation: moving robotic biopsy from operating theatre to clinic. J Robot Surg. 2020 Feb 12. doi: 10.1007/s11701-020-01052-z. (IF 2.715)
  52. Tung JYM, Chen K, Sim ASP. Indocyanine green-guided laparoscopic renal pedicle lymphatic disconnection: A novel, targeted treatment for chyluria. Int Braz J Urol. 2019 Mar 20;45. (IF 1.342)
  53. Lee A, Lee HJ, Huang HH, Ho H, Chen K. Low-risk Non-muscle Invasive Bladder Cancer – Further Prognostic Stratification into “Very Low-risk” group based on tumour size. Int J Urol. 2019 Apr;26(4):481-486. (IF 2.896)
  54. Chen K, Xin Yan Yang, Karine Sim, Mahmood B. Mohammad, Kae Jack Tay, Allen Sim, Yuen SP J. Total Extra-peritoneal (TEP) Robotic-assisted Laparoscopic Radical Prostatectomy – Step-by-step Approach. Journal of Endourology, Part B: Videourology Vol. 33, No. 2. Published Online:27 Mar 2019 (JIF 2.619)
  55. Chen K, Lee A, Huang HH, Tay KJ, Sim A, Lee LS, Cheng C, Ng LG, Ho H, Yuen SP J. Evolving trends in the surgical management of renal masses over the last two decades: a contemporary picture from a large prospectively-maintained database. Int J Urol. 2019 Apr;26(4):465-474. (IF 2.896)
  56. Jin Yong, Chen K, Allen Sim, Endoscopic Management of Giant Bladder Stones: The Elegant Choice, Videourology Vol 33, No. 1. Published Online:30 Jan 2019 (IF 2.619)
  57. Lee HJ, Chen K, Molchanov R, Schwentner C, Sim ASP. Feasibility of utilizing near-infrared fluorescence imaging with indocyanine green for super-selective arterial clamping in pure laparoscopic partial nephrectomy. Int J Urol. 2018 Apr;25(4):382-383. doi: 10.1111/iju.13525. (IF 2.896)
  58. Chen K, Tan YG, Tan D, Pek G, Huang HH, Sim AS A. Predictors and outcomes of laparoscopic nephrectomy in autosomal dominant polycystic kidney disease. Investig Clin Urol. 2018 Jul;59(4):238-245. (IF 1.902)
  59. Lim WS, Chen K, Chong Tsung Wen et al. A bilayer swellable drug-eluting ureteric stent: Localized drug delivery to treat urothelial diseases. Biomaterials 2018. Biomaterials. 2018 May;165:25-38. doi: 10.1016/j.biomaterials.2018.02.035. (IF 15.3)
  60. Chen K, Tay KJ, Law YM, Aydin H, Ho H, Cheng C, Yuen JS. Outcomes of Combination MRI-targeted and Transperineal Template Biopsy in Restaging Low-risk Prostate Cancer for Active Surveillance. Asian J Urol. 2018 Jul;5(3):184-193. (IF 2.784)
  61. Chen K, Sim A, Kan AF. The effect of adjunct caudal block on postoperative analgesia in robot-assisted laparoscopic radical prostatectomy: a prospective randomized controlled, single blinded study in a tertiary centre. Asian J Urol. 2018 Apr;5(2):122-126. doi: 10.1016/j.ajur.2017.06.009. (IF 2.784)
  62. Chen K, Lee BL, Huang HH, Tan BY, Lee LS, Ng LG, Lau W, Yuen JS. Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma. Int J Urol. Volume 24, Issue 1 January 2017 Pages 51–58 (IF 2.896)
  63. Chen K, Huang HH, Aydin H, Tan YH, Lau WK, Cheng CW, Yuen JS. Renal cell carcinoma in patients with end-stage renal disease is associated with more favourable histological features and prognosis. Scand J Urol. 2015 Mar 17:1-5. (IF 1.899)
  64. Chen K, Eu E, Tan YG, Ho H, Sim A, Schwentner C. "Zero-ischemia laparoscopic partial nephrectomy with hydrodissection: technique and early experience from a multicentre study" Videourology Vol. 32, No. 1. Published online 1 Feb 2018 (IF 2.619)
  65. Tiwari Raj, Chen K, Phang Allen Sim Soon. Zero Ischemia, Indocyanin Green-Assisted Robotic Heminephroureterectomy for a Duplicated Renal Collecting System. Videourology, Vol. 32, No. 2. Published online 6 Apr 2018. (IF 2.619)
  66. Lee Han Jie, Chen Kenneth, Molchanov Robert, Schwentner Christian, Soon Phang Sim, Allen. (2018). Feasibility of utilizing near-infrared fluorescence imaging with indocyanine green for super-selective arterial clamping in pure laparoscopic partial nephrectomy. Int J Urol. 2018 Apr;25(4):382-383. (IF 2.896)
  67. Fong SS, Chen K, Sim R, Chronic anastomotic sinus after low anterior resection: When can the defunctioning stoma be reversed? Colorectal Dis. 2011 Jun;13(6):644-9. doi: 10.1111/j.1463-1318.2010.02245.x. Epub 2010 Feb 20. (IF 3.917)
  68. Tan KK, Chen K, Liau KH, Ho CK, Pancreatic tuberculosis mimicking pancreatic carcinoma: series of three cases, Eur J Gastroenterol Hepatol. 2009 Nov;21(11):1317-9. (IF 2.586)
  69. Tan KK, Chen K, Chia KH, Lee CW, Nalachandran S., Surgical management of infected pseudoaneurysms in intravenous drug abusers: single institution experience and a proposed algorithm, World J Surg. 2009 Sep;33(9):1830-5. (IF 3.352)
  70. Tan KK, Chen K, Sim R., The spectrum of abdominal tuberculosis in a developed country: a single institution's experience over 7 years, J Gastrointest Surg. 2009 Jan;13(1):142-7. (IF 3.267)

Research Trials

SingHealth Updates for Healthcare Professionals

HealthXchange E-news Subscription

Health Buddy App

About Us
Patient Care
Education
Research
Careers
Giving
SingHealth
SingHealth Duke-NUS
Singapore General Hospital, Outram Road, Singapore 169608 +65 6222 3322

© 2024 SingHealth Group. All Rights Reserved.